F
or more than 100 years, the billionaire Angelini family had been content to run a largely European business empire from their headquarters in Rome: pharmaceuticals like the Italian equivalent of Tylenol and the antidepressant trazodone, as well as a robotics business, wineries (of course) and a joint venture with Procter & Gamble to sell Pampers and other consumer products in their native Italy.
But after former banker and law professor Sergio Marullo di Condojanni married Thea Paola Angelini, now the family’s fourth-generation controlling shareholder, in 2017, the two began plotting a major expansion of Angelini Pharma, its drug business…
Read the full article at FORBES.COM
